Blood Thinners and Cosmetic Surgery in Korea: Warfarin, Apixaban, Aspirin Management

Patients on anticoagulants (blood thinners) face complex decisions before cosmetic surgery — bleeding risk during surgery vs. clotting risk during medication hold. The right approach depends on the underlying reason for anticoagulation and the procedure type. Korean clinics coordinate with home prescribing physicians for individualized strategies. This FAQ explains the considerations.

Common anticoagulants Korean cosmetic patients take

• Warfarin — long-standing classic; INR-monitored.
• Direct oral anticoagulants (DOACs) — apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), edoxaban (Savaysa).
• Aspirin — antiplatelet, low-dose for cardiovascular protection.
• Clopidogrel (Plavix) — antiplatelet for cardiac stents.
• Heparin — IV; injectable forms for bridging.
• Ticagrelor (Brilinta) — newer antiplatelet.

The fundamental tension

Continuing medication

• Increased intra-operative bleeding.
• Hematoma risk post-op.
• Bruising more pronounced.
• Wound complications.
• Maintains stroke/clot prevention.

Holding medication

• Better surgical hemostasis.
• Reduced bleeding complications.
• Increased thrombotic risk during hold period.
• Stroke or clot during cosmetic surgery devastating.
• Decision balances both risks.

Risk stratification

High-risk for clot if held

• Mechanical heart valve (especially mitral).
• Recent (<3 months) DVT or PE.
• Recent stroke.
• Atrial fibrillation with high CHA2DS2-VASc score.
• Active cancer with thrombosis history.
• Recent cardiac stent (<6 months).

Lower-risk for clot if held

• Stable atrial fibrillation, low CHA2DS2-VASc.
• Old DVT/PE (>6 months).
• Aspirin for primary prevention only.
• Conservative anticoagulation indication.

Procedure bleeding risk levels

Low bleeding risk (continue typically)

• Botox injections.
• Filler injections (cannula technique).
• Most laser treatments.
• Skin biopsies.
• Conservative non-surgical procedures.

Moderate bleeding risk (hold consideration)

• Eyelid surgery.
• Brow lift.
• Lip lift.
• Liposuction (small volume).
• Most cosmetic surgical procedures.

High bleeding risk (typically hold)

• Facelift.
• Breast surgery.
• Major body contouring.
• Long surgical procedures.
• Procedures with substantial dissection.

Common patient questions

I take aspirin for my heart — should I stop before cosmetic surgery?

Discuss with cardiologist. Generally: aspirin for primary prevention can be held 7 days. Aspirin after recent cardiac event or stent — typically continue. Risk of stopping may exceed bleeding benefit.

I\'m on Eliquis (apixaban) for atrial fibrillation. Can I have rhinoplasty?

Yes, with coordinated planning. Hold typically 48 hours pre-op. Resume 24–48 hours post-op once hemostasis confirmed. Coordinate with prescribing cardiologist. Bridging with heparin sometimes considered for higher-risk patients.

I take warfarin. How long before surgery should I stop?

Typically 5 days for INR to normalize. Bridging with heparin may be needed for high-risk patients. Coordinate carefully with anticoagulation clinic.

What about facelift on Plavix?

Major decision. Plavix typically held 5–7 days before high-bleeding-risk procedures. But Plavix often required for recent cardiac stents — stopping can cause stent thrombosis. Cardiology consultation essential before decision.

Can I take aspirin or NSAIDs for headache before surgery?

Stop 7 days before for cosmetic surgery generally. Tylenol acceptable. Read labels carefully — many OTC products contain NSAIDs.

What\'s "bridging therapy"?

Stopping long-acting anticoagulant (warfarin) and substituting short-acting heparin near surgery time. Surgical hold is short. Heparin allows faster reversal. Used for high-thrombosis-risk patients undergoing major surgery.

Korean clinical approach

Standard practice

• Disclose all blood thinners at consultation.
• Confirm with anesthesia team.
• Coordinate with home prescribing physician.
• Develop specific pre-op hold plan.
• Document plan in medical record.
• Resume schedule planned in advance.

Anesthesia adjustments

• Intra-operative bleeding monitoring.
• Hemostasis tools and techniques.
• Possible blood product availability.
• Closer post-op monitoring.

Specific medication hold guidelines

Warfarin

• Stop 5 days before surgery.
• Confirm INR normalization (1.0–1.4) day before.
• Bridging with heparin for high-risk patients.
• Resume 24–48 hours post-op typically.
• Re-warfarinization period.

Apixaban (Eliquis)

• Stop 48 hours before high-bleeding-risk surgery.
• Stop 24 hours before low-risk procedures.
• Resume 24–48 hours post-op.
• Faster restart than warfarin.

Rivaroxaban (Xarelto)

• Stop 24 hours before low-risk procedures.
• Stop 48 hours before high-risk.
• Resume 24 hours post-op.

Dabigatran (Pradaxa)

• Hold longer in renal impairment (effect prolonged).
• Stop 24–48 hours typically.
• Stop 4+ days for high bleeding risk and CKD.

Aspirin

• Stop 7 days for cosmetic surgery generally.
• Continue if recent cardiac event.
• Cardiologist consultation if held.

Clopidogrel (Plavix)

• Stop 5–7 days before high-bleeding-risk surgery.
• Continue for recent cardiac stents.
• Cardiology consultation essential.

Coordination requirements

What information to bring

• Specific medication and dose.
• Reason for anticoagulation.
• How long on medication.
• Recent INR if on warfarin.
• Cardiology or hematology contact.
• Recent labs.

Letter from prescribing physician should include

• Specific perioperative hold and resumption recommendations.
• Alternative bridging strategy if applicable.
• Risk-benefit assessment of hold.
• Direct contact for questions.
• Resumption monitoring plan.

For international patients

• Bring full prescription bottles in original packaging.
• Allow extra time for coordination with home physician.
• Consider longer Korea stay for resumption monitoring.
• Bring INR home monitor if on warfarin.
• Plan medication continuity for trip back.
• Document any bleeding or clotting symptoms.

Red flags to avoid

• Korean clinic willing to proceed without coordination with home physician.
• Bridging recommendations without anticoagulation specialty input.
• Unilateral medication hold without prescribing physician knowledge.
• Cosmetic surgery during recent cardiac event.
• Major elective surgery with very recent stroke.

Emergency considerations

If bleeding develops post-op

• Notify clinic immediately.
• Specific reversal agents may be needed.
• Vitamin K for warfarin.
• Idarucizumab for dabigatran.
• Andexanet alfa for apixaban/rivaroxaban.
• Korean major hospitals stock these; small clinics may not.

If clot develops during hold

• Resume anticoagulation immediately.
• Bridging with heparin if needed.
• Monitor for stroke or PE symptoms.
• Emergency medical evaluation.

What patients should know

• Anticoagulation isn\'t a barrier to cosmetic surgery — it requires planning.
• Hold strategy individual; depends on indication and procedure.
• Coordinate with home prescribing physician.
• Don\'t make medication decisions unilaterally.
• Major procedures may need home-country location with reversal agent availability.
• Expect more pre-op planning time.

The honest framing

Blood thinners and cosmetic surgery require thoughtful coordination — not avoidance. The patients who manage this well coordinate carefully with home prescribers, bring detailed documentation, accept individualized hold strategies, and recognize that the trade-off between bleeding and clotting is real. The patients who unilaterally stop medications or hide them from surgical teams face either bleeding complications or thrombotic events. Korean clinics serving anticoagulated patients can manage this well with proper coordination — but the planning is the patient\'s responsibility to initiate. Don\'t pursue cosmetic surgery without involving your prescribing physician in the timing and hold strategy.